| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.086 | 0.1 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.077 | 0.1 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | -0.052 | 0.1 |